ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
60 977,85
0,30%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aevi Genomic Medicine Inc (GNMX)

  7. Aevi Genomic Medicine Inc (GNMX) Actualités

GNMX

Aevi Genomic Medicine (GNMX)

Aevi Genomic Medicine Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GNMX
DateHeureSourceTitreSymboleSociété
14/02/202022h25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
14/02/202016h57Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:GNMXAevi Genomic Medicine Inc
14/02/202012h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202021h49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202021h42Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202021h40Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202018h58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202018h58Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202018h57Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GNMXAevi Genomic Medicine Inc
03/02/202022h32Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:GNMXAevi Genomic Medicine Inc
03/02/202022h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNMXAevi Genomic Medicine Inc
03/02/202022h15GlobeNewswire Inc.Cerecor and Aevi Genomic Medicine Complete MergerNASDAQ:GNMXAevi Genomic Medicine Inc
06/01/202022h07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GNMXAevi Genomic Medicine Inc
31/12/201922h47Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:GNMXAevi Genomic Medicine Inc
23/12/201913h32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GNMXAevi Genomic Medicine Inc
16/12/201913h30GlobeNewswire Inc.NexImmune Appoints Sol Barer as Chairman of the Board of DirectorsNASDAQ:GNMXAevi Genomic Medicine Inc
11/12/201912h02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GNMXAevi Genomic Medicine Inc
05/12/201914h45GlobeNewswire Inc.Cerecor to Acquire Aevi Genomic MedicineNASDAQ:GNMXAevi Genomic Medicine Inc
14/11/201914h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GNMXAevi Genomic Medicine Inc
15/10/201914h00PR Newswire (US)Aevi Genomic Medicine, Inc. Receives Positive Nasdaq Listing DeterminationNASDAQ:GNMXAevi Genomic Medicine Inc
07/08/201914h00PR Newswire (US)Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 AntibodyNASDAQ:GNMXAevi Genomic Medicine Inc
07/08/201912h04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GNMXAevi Genomic Medicine Inc
06/08/201923h12Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:GNMXAevi Genomic Medicine Inc
06/08/201914h00PR Newswire (US)Aevi Genomic Medicine to Present at the 2019 Wedbush PacGrow Healthcare ConferenceNASDAQ:GNMXAevi Genomic Medicine Inc
26/07/201923h19Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GNMXAevi Genomic Medicine Inc
15/07/201922h05PR Newswire (US)Aevi Genomic Medicine Enters into Worldwide License Agreement with Astellas to Develop and Commercialize a Novel Second Gener...NASDAQ:GNMXAevi Genomic Medicine Inc
30/04/201914h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GNMXAevi Genomic Medicine Inc
29/03/201922h29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/201914h25GlobeNewswire Inc.Factors of Influence in 2019, Key Indicators and Opportunity within Park Hotels & Resorts, Planet Fitness, Aevi Genomic Medic...NASDAQ:GNMXAevi Genomic Medicine Inc
02/01/201922h30PR Newswire (US)Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children w...NASDAQ:GNMXAevi Genomic Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:GNMX

Dernières Valeurs Consultées

COIN
BTCUSD
Bitcoin
EU
CS
Axa
EU
AI
Air Liquide
EU
ML
Michelin
NASDAQ
MSFT
Microsoft
NASDAQ
AAPL
Apple
EU
VIV
Vivendi
FTSE
UKX
FTSE 100
NASDAQ
AMZN
Amazon.com
EU
RNO
Renault
USI
USTECH100
US Tech 100
EU
BN
Danone
NYSE
KO
Coca Cola
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés